Read our latest analysis from the #ADVOR trial @JACCJournals. Deeper dive into the relationship of #natriuresis with decongestion & clinical outcomes after diuretic therapy in acute #heartfailure! Tweetorial below...
In relative terms: effect on natriuresis > urine output, UO🚫significant after 1st diuretic dose, natriuresis remained high!
*Normalized UO to 24 h for collection 1.
Moreover, allocation to #acetazolamide by a landslide strongest predictor of both urine #sodium concentration (UNa) AND total #natriuresis (molecules excreted)!
For instance, 5-8x bigger impact than an eGFR change of 10 mL/min/1.73m²
Be wary: total natriuresis and UNa not the same!
Total natriuresis tracks well with UO
➡️Amount of extracellular volume (ECV) DURABLY removed (150 mmol Na ~ 1 L ECV)
❗️Urine is usually HYPOTONIC (UNa <150 mmol/L)
➡️Part of UO reflects #dehydration rather than #decongestion
Thus, #acetazolamide
✅Keeps sodium content of urine high, therefore allowing better decongestion for same UO!
Higher UNa & greater total natriuresis
✅Associated with higher chance of successful #decongestion (no more than trace edema and no ascites/pleural effusion)
From 1st morning, patients w higher UNa (less Na avidity): significantly greater clinical decongestion!
UNa ≥80 ideal cut-off, indicating excellent response!
❗️Intriguingly, effect of #acetazolamide on decongestion🚫significant after adjustment for natriuresis➡️Mediation?
Consequently, patients with better natriuresis has a shorter length of stay
✅4.5 days shorter for UNa ≥100 versus <50 mmol/L
As shown in other studies, better natriuretic response to #diuretics was associated with better clinical outcome (death or heart failure readmissions)
Now the intriguing part:
Good natriuretic response (UNa ≥80 mmol/L):
➡️Similar outcome loop diuretic monotherapy & combination with acetazolamide
❗️Many more patients with #acetazoalmide had UNa ≥80 mmol/L (NNT = only 7!)
Poor natriuretic response (UNa <80 mmol/L):
🪦 &🏥
Also, for people that are so concerned about the non-significantly🔼90-day 🪦 with #acetazolamide in #ADVOR:
* Notice LATE occurrence of this effect (45 days after randomization or >30 days after acetazolamide was stopped)
* Mostly in patients with a poor natriuretic response
My interpretation is that by the play of chance, patients in the #acetazolamide arm were probably slightly sicker.
Illustrated as well by slightly higher baseline dose of loop diuretics (80 vs. 60 mg furosemide equivalents).
Conclusion: 1. Upfront combination of #acetazolamide with loop diuretics in acute #heartfailure helps to keep sodium content of urine high. 2. Strong natriuresis ~ better (and more durable?) decongestion! 3. Natriuretic response ~ clinical outcomes
It shows nicely that after 48 h treatment with monotherapy loop diuretics, almost every patient develops "contraction alkalosis"
We need to rename "contraction alkalosis" to "neurohumoral alkalosis", as it is not a sign of hypovolemia per se.
Thus:
➡️Minor congestion requiring 1 or 2 doses of diuretics probably does not need #acetazolamide
➡️In case of any prolonged treatment: UPFRONT!!!
This is a BIG difference with #thiazides, which have shown to break diuretic resistance, can wait until this occurs!
The effect of #acetazolamide resides in braking the neurohumoral system, so need to treat upfront rather than bail-out, which is how #ADVOR was set up!
For the #physiology fans, here's the paper in which we discussed the proximal nephron hypothesis, leading to the #ADVOR trial @ESC_Journals :
#hyponatremia in #heartfailure 🟰 mainly dilutional: ➡️Impaired water excretion & extracellular volume expansion!
However, we tend to underestimate the depletional component due to chronic potassium and magnesium losses
➡️Intracellular dehydration
➡️Intracellular sodium shift
Replenishing potassium & magnesium stores alone actually increases serum Na in depletional hyponatremia!
K & Mg go intracellular ➡️Na goes back extracellular
Best K level probably ~4.5 mmol/L
3.5-4.0 mmol/L: K deficit ~ 200 mmol (!), so be aggressive!
Teaming up again with the great @VerwerftJan to share our experience with #echoCPET in #HFpEF. This hot-of-the-press paper @ESC_Journals demonstrates myriad of opportunities for diagnosis & treatment, far beyond #SGLT2i only. Tweetorial below!
In #HFpEF, early & correct diagnosis are important, #phenotyping is everything. There are a lot of mechanisms for dyspnoea involved
Current @ESC_Journals paper goes one step further: "In patients with confirmed HFpEF or probability >90% according to well-validated HFpEF scores (both are complimentary in our view), why #echoCPET within a dedicated #dyspnoea clinic? What is the impact of findings?"
From #ADVOR population, we included 462 or 89% of patients with 2 correctly performed consecutive urine collections and urine sodium concentration (UNa) available.
Natriuresis:
- UNa [mmol/L] ~ diuretic efficiency
- Total natriuresis [mmol] ~ ECV & interstitial Na buffer removed
#Acetazolamide, after multivariate adjustment, was strongest predictor of #natriuresis in #ADVOR:
UNa + 16 mmol/L
Total natriuresis +115 mmol
👊 within 2 days !!!
👍 much stronger than effect on urine output itself
What is your take on #vasodilators in acute #HeartFailure? The upcoming November issue of #EHJACVC will bring you a PRO/CON "Vasodilator therapy in acute heart failure revisited"
As our PRO paper was published in advanced access, a sneak preview Tweetorial below...
First some background...
Current @escardio guidelines state (IIb, B): "In patients with AHF and a systolic blood pressure (SBP) >110 mmHg, intravenous vasodilators may be considered as an initial therapy to improve symptoms and reduce congestion."
Only 1 flowchart has them in...
So far, I consider this a fair recommendation... In hyper/normotensive pulmonary oedema, they might be helpful in some cases, with their main benefit a reduced need for (non-)invasive ventilation!
Extremely proud that our journal offers a platform to 3 great clinicians & Twitter educators. I always learn from them...
A strong argument is made to switch mainstream thinking in #AKI away from the fallacious concept of fluid responsiveness in all to a primary assessment of fluid tolerance.
Probably the most important thing I have learned on Twitter: #VExUS
Why do I like #VExUS so much? Because it really changed my everyday practice... Portal vein became part of my standard #echocardiography assessment.
And that's what we want to achieve with this review, offer something directly applicable at your bedside!
For those who can't get enough from #ADVOR, below the promised Tweetorial!
Acetazolamide in acute #HeartFailure w volume overload on background high-dose loop diuretics:
👍Increases diuresis & natriuresis
👍More euvolemia after 3 days & discharge
👍⬇️LOS #ESCCongress#Cardiology
First, the unsung hero's of this trial, done with a little bit over 2 million €, bargain for largest diuretic #RCT ever! @KatrienTartagl2 & her team, with only 3FTE, they ran the most successful trial in #AHF @PieterMartensMD & @JeroenDauw who did most fieldwork
👏
How did we come up with the idea? Actually, cause we all love #physiology. Credits go to Prof. Em. Paul Steels who teached us all how kidneys work. @GLW_UHasselt
65% of sodium is reabsorbed in the proximal tubules, can be up to 85% in #HeartFailure